AXNX stock: buy or sell?
July 15th, 2019
Should I buy AXNX stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to define your own trading plan that fits your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Axonics Modulation Technologies stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Axonics Modulation Technologies stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we gathered 3 ratings published for AXNX stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-6-13||Bank of America||n/a||Buy|
AXNX stock analysis
Shares of Axonics Modulation ended today at $40.16 and stayed steady a tight -0.07%.
Axonics Modulation shares stayed constant -0.07% to $40.16 today. AXNX shows a short term strength with several rising tops and rising bottoms. In the very short term, on Wednesday it marked a new bottom at $39.11 that should act a support if Axonics Modulation Technologies starts a trading flat base in the range of $39.11 - $43.37 Trading the long side, we should wait to a new breakout over $43.37 to find the next buy point. On July/2, AXNX hit a new all time high, pushing higher than on Jul 1st tops. Check different trading setups that use ATHs as triggers. On May AXNX price bounced up over the SMA of 50 days demonstrating to be a significant support for this stock.
Axonics Modulation Technologies remained constant a tight -0.07% this week. Late June AXNX skyrocketed a super good 7.49% in just one week. For 3 weeks in a row, price slid and lost a -2.14%.
Axonics Modulation stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, AXNX might consolidate in a flat-base, waiting to break out over or down under . Not so far away is the last price record Axonics Modulation marked early July. Since price and SMA10w lines crossed up early May, AXNX climbed $17.67 (78.57%).
AXNX stock price history
AXNX IPO was on October at $16.05 per share1. Since then, AXNX stock grew a 150.20%, with a yearly average of inf%. If you had invested right after AXNX's IPO a $1,000 in AXNX stock in 2018, it would worth $1,502.00 today.
1: Adjusted price after possible price splits or reverse-splits.
AXNX stock historical price chart
AXNX stock reached all-time highs on July/2 with a price of $43.37.
AXNX stock price target is $31.30How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We have 3 price targets for AXNX stock released in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-6-13||Bank of America||Raises Target||$30.00||$35.00||16.7%|
|2019-5-10||SunTrust Banks||Raises Target||n/a||$33.00||-|
|2019-3-5||SunTrust Banks||Raises Target||n/a||$26.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareAxonics Modulation presented astounding results for 2018-Q4 on March. Axonics Modulation rocketed Earnings per Share (EPS) by 56.30%, beating analysts of $-0.32. Axonics Modulation posted $-0.50.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw an astounding gain of 452.34% to $0.71 million dollars. When comparing 2018 vs 2017, in the same way, profit margin (that is, the net income divided by revenues) rocketed a 9,054.32% to -4,596.46%.
|2017||$0.13 M||-||$-17.47 M-13650.8%||-|
|2018||$0.71 M||452.34%||$-32.50 M-4596.5%||85.98%|
Quarterly financial resultsAxonics Modulation Technologies posted $0.49 M in sales for 2018-Q4, a 145.77% improvement compared to previous quarter. Reported quarter income marked $-9.68 M with a profit margin of -1,958.50%. Profit margin climbed a 1,806.17% compared to previous quarter when profit margin was -3,764.68%. When comparing turnover to same quarter last year, Axonics Modulation sales marked an exceptional gain and boosted a inf%. Looking back to recent quarterly results, Axonics Modulation Technologies posted 2 positive quarters in a row.
|2017-Q3||$0.13 M||-||$-4.00 M-3127.3%||-|
|2018-Q3||$0.20 M||57.03%||$-7.57 M-3764.7%||89.03%|
|2018-Q4||$0.49 M||145.77%||$-9.68 M-1958.5%||27.86%|
Axonics Modulation ownershipWhen you are planning to invest in shares of a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Axonics Modulation Technologies, 18.64% of all outstanding shares are owned by its staff.
In case of Axonics Modulation stock, 79.43% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AXNX stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Axonics Modulation Technologies:
|Market cap||$1.1 B|
|Total shares||28.3 M|
|Float shares||9.9 M|
|- Institutional holdings (%)||79.4%|
|- Insider holdings (%)||18.6%|
|Shares in short selling||0.0%|
|Monday, July 15th, 2019|
|Day range||$39.64 - $41.22|
|Average true range||$1.87|
|50d mov avg||$33.90|
|100d mov avg||$27.72|
|200d mov avg||$0.00|
Axonics Modulation performanceTo measure stock performance is always good to benchmark with competitors or related stocks. In the following table, we compare Axonics Modulation performance to :